Carrie A. Young

536 total citations
6 papers, 392 citations indexed

About

Carrie A. Young is a scholar working on Psychiatry and Mental health, Pharmacology and Neurology. According to data from OpenAlex, Carrie A. Young has authored 6 papers receiving a total of 392 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Psychiatry and Mental health, 4 papers in Pharmacology and 1 paper in Neurology. Recurrent topics in Carrie A. Young's work include Schizophrenia research and treatment (6 papers), Treatment of Major Depression (4 papers) and Dementia and Cognitive Impairment Research (2 papers). Carrie A. Young is often cited by papers focused on Schizophrenia research and treatment (6 papers), Treatment of Major Depression (4 papers) and Dementia and Cognitive Impairment Research (2 papers). Carrie A. Young collaborates with scholars based in United States, Canada and France. Carrie A. Young's co-authors include Alan Breier, Walter Deberdt, Donald P. Hay, Peter D. Feldman, Deborah Lehman, Scot E. Purdon, Richard S.E. Keefe, James M. Gold, Stephanie Rock and Manuel Martín Carrasco and has published in prestigious journals such as Schizophrenia Research, The Journal of Clinical Psychiatry and International Journal of Geriatric Psychiatry.

In The Last Decade

Carrie A. Young

6 papers receiving 374 citations

Peers

Countries citing papers authored by Carrie A. Young

Since Specialization

Citations

This map shows the geographic impact of Carrie A. Young's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Carrie A. Young with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Carrie A. Young more than expected).

Fields of papers citing papers by Carrie A. Young

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Carrie A. Young. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Carrie A. Young. The network helps show where Carrie A. Young may publish in the future.

Co-authorship network of co-authors of Carrie A. Young

This figure shows the co-authorship network connecting the top 25 collaborators of Carrie A. Young. A scholar is included among the top collaborators of Carrie A. Young based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Carrie A. Young. Carrie A. Young is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

6 of 6 papers shown

#	Work	Indexed citations
1	A Review of Treatment-Emergent Adverse Events During Olanzapine Clinical Trials in Elderly Patients With Dementia 2006 ·The Journal of Clinical Psychiatry ·Ludmila Kryzhanovskaya, Dilip V. Jeste, Carrie A. Young, John Polzer, (unknown), (unknown), Janice Carlson, Patrizia Cavazzoni	25
2	One-year double-blind study of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in schizophrenia 2005 ·Schizophrenia Research ·Richard S.E. Keefe, Carrie A. Young, Stephanie Rock, Scot E. Purdon, James M. Gold, Alan Breier	116
3	Comparison of Olanzapine and Risperidone in the Treatment of Psychosis and Associated Behavioral Disturbances in Patients With Dementia 2005 ·American Journal of Geriatric Psychiatry ·Walter Deberdt, Maurice W. Dysken, (unknown), Peter D. Feldman, Carrie A. Young, Donald P. Hay, Deborah Lehman, Martín Dossenbach, Elisabeth K. Degenhardt, Alan Breier	94
4	Olanzapine versus placebo in the treatment of psychosis with or without associated behavioral disturbances in patients with Alzheimer's disease 2004 ·International Journal of Geriatric Psychiatry ·Peter Paul De Deyn, Manuel Martín Carrasco, Walter Deberdt, Claude Jeandel, Donald P. Hay, Peter D. Feldman, Carrie A. Young, Deborah Lehman, Alan Breier	142
5	A one-year double-blind comparison of the neurocognitive efficacy of olanzapine, risperidone, and haloperidol in patients with schizophrenia 2003 ·Schizophrenia Research ·Alan Breier, R.S.E. Keefe, Carrie A. Young, Scot E. Purdon, (unknown), Keith L. Davis	9
6	Cost-effectiveness of olanzapine compared to risperidone and haloperidol in the treatment of patients with schizophrenia: Results from a U.S. randomized controlled trial 2003 ·Schizophrenia Research ·M. Namjoshi, Carrie A. Young, Loulin Huang, E.T. Edgell, Alan Breier	6

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact